Nuvalent Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)
Nuvalent (NUVL) Gets a Buy From Stifel Nicolaus
Nuvalent's Promising Clinical Progress and Financial Stability Support Strong Buy Rating
Nuvalent Analyst Ratings
Nuvalent Analyst Ratings
Nuvalent Analyst Ratings
Nuvalent Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Arcutis Biotherapeutics (ARQT)
Analysts' Top Healthcare Picks: Privia Health Group (PRVA), Nuvalent (NUVL)
Nuvalent Analyst Ratings
Wedbush Raises Nuvalent's Price Target to $99 From $82, Maintains Outperform Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), NewAmsterdam Pharma Company (NAMS) and Marinus (MRNS)
Hold Rating on Nuvalent Continues: Evaluating the Potential of NVL-655 and Anticipated Market Shifts
TD Cowen Keeps Their Buy Rating on Nuvalent (NUVL)
Piper Sandler Remains a Buy on Nuvalent (NUVL)
BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $79
Nuvalent Analyst Ratings
Nuvalent (NUVL) Gets a Buy From Stifel Nicolaus
Promising Performance of Nuvalent's NVL-655 and Its Potential Impact on ALK+ NSCLC Treatment: A Buy Recommendation